Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 19, 2019
Antimicrobial Stewardship in Cancer Patients: The Time is Now
Samuel L Aitken, Jerod L Nagel, Lilian Abbo, et al.
Frontiers in Cellular and Infection Microbiology
|
April 18, 2022
Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
Samantha Franklin, Samuel L Aitken, Yushi Shi, et al.
Infection Control and Hospital Epidemiology
|
August 21, 2015
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent
Samuel L Aitken, M Jahangir Alam, Mohammed Khaleduzzaman, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
High-level ceftazidime-avibactam resistance in <i>Escherichia coli</i> conferred by the novel plasmid-mediated beta-lactamase CMY-185 variant
William C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 5, 2017
Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens
Samuel A Shelburne, Jiwoong Kim, Jose M Munita, et al.
The Journal of Antimicrobial Chemotherapy
|
November 9, 2020
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort
William C Shropshire, Samuel L Aitken, Reed Pifer, et al.
Journal of the American College of Clinical Pharmacy : JACCP
|
September 28, 2020
Precision Pharmacotherapy: Integrating Pharmacogenomics into Clinical Pharmacy Practice
J Kevin Hicks, Christina L Aquilante, Henry M Dunnenberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 18, 2016
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center
Samuel L Aitken, Jeffrey J Tarrand, Lalitagauri M Deshpande, et al.
Infectious Diseases and Therapy
|
November 28, 2022
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer
Denise Marie A Francisco, Liangliang Zhang, Ying Jiang, et al.
International Journal of Antimicrobial Agents
|
July 9, 2019
Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia
Lindsay M Avery, Joseph L Kuti, Maja Weisser, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 19, 2019
Antimicrobial Stewardship in Cancer Patients: The Time is Now
Samuel L Aitken, Jerod L Nagel, Lilian Abbo, et al.
Frontiers in Cellular and Infection Microbiology
|
April 18, 2022
Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
Samantha Franklin, Samuel L Aitken, Yushi Shi, et al.
Infection Control and Hospital Epidemiology
|
August 21, 2015
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent
Samuel L Aitken, M Jahangir Alam, Mohammed Khaleduzzaman, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
High-level ceftazidime-avibactam resistance in <i>Escherichia coli</i> conferred by the novel plasmid-mediated beta-lactamase CMY-185 variant
William C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 5, 2017
Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens
Samuel A Shelburne, Jiwoong Kim, Jose M Munita, et al.
The Journal of Antimicrobial Chemotherapy
|
November 9, 2020
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort
William C Shropshire, Samuel L Aitken, Reed Pifer, et al.
Journal of the American College of Clinical Pharmacy : JACCP
|
September 28, 2020
Precision Pharmacotherapy: Integrating Pharmacogenomics into Clinical Pharmacy Practice
J Kevin Hicks, Christina L Aquilante, Henry M Dunnenberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 18, 2016
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center
Samuel L Aitken, Jeffrey J Tarrand, Lalitagauri M Deshpande, et al.
Infectious Diseases and Therapy
|
November 28, 2022
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer
Denise Marie A Francisco, Liangliang Zhang, Ying Jiang, et al.
International Journal of Antimicrobial Agents
|
July 9, 2019
Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia
Lindsay M Avery, Joseph L Kuti, Maja Weisser, et al.
Page
of 11